• 1. Emerging themes in soft matter: responsive and active soft materials
  Julia M. Yeomans Soft Matter, 2010,6, 703-704
• 2. Fe3O4@SiO2 core–shell nanoparticles for biomedical purposes: adverse effects on blood cells?
  C. Achilli,G. F. Guidetti,A. Ciana,D. Capsoni,G. Minetti Biomater. Sci., 2016,4, 1417-1421
• 3. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 4. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 5. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683

Introduction to Tert-butyl 6-oxo-2,7-diazaspiro[4.5]decane-2-carboxylate (CAS No. 1228631-64-8)

Tert-butyl 6-oxo-2,7-diazaspiro[4.5]decane-2-carboxylate, identified by its Chemical Abstracts Service (CAS) number 1228631-64-8, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the spirocyclic class of molecules, characterized by its unique structural framework that integrates a carbonyl group, a tert-butyl moiety, and a diazaspiro structure. The spirocyclic core, specifically spiro[4.5]decane, contributes to the molecule's rigidity and stability, making it a promising scaffold for the development of novel bioactive agents.

The diaza moiety in the molecule introduces nitrogen atoms into the spirocyclic system, which can significantly influence its electronic properties and biological interactions. This feature makes tert-butyl 6-oxo-2,7-diazaspiro[4.5]decane-2-carboxylate a versatile intermediate in organic synthesis, particularly in the construction of more complex pharmacophores. The presence of the tert-butyl group further enhances the compound's lipophilicity and metabolic stability, attributes that are highly desirable in drug design.

Recent advancements in medicinal chemistry have highlighted the potential of spirocyclic compounds as lead molecules for therapeutic intervention. Studies have demonstrated that spirocycles exhibit unique conformational preferences and binding affinities, which can be exploited to develop drugs with improved pharmacokinetic profiles. For instance, derivatives of spiro[4.5]decane have been investigated for their role in modulating enzyme activity and receptor binding, particularly in neurological and cardiovascular applications.

The carboxylate functionality at the 2-position of the spirocycle provides a reactive handle for further chemical modifications, enabling the synthesis of ester analogs or amides that can be tailored for specific biological targets. This adaptability has made tert-butyl 6-oxo-2,7-diazaspiro[4.5]decane-2-carboxylate a valuable building block in drug discovery campaigns.

In terms of synthetic methodology, the preparation of tert-butyl 6-oxo-2,7-diazaspiro[4.5]decane-2-carboxylate involves multi-step organic transformations, including cyclization reactions and protection-deprotection strategies to ensure regioselectivity and functional group compatibility. The synthesis often requires careful optimization to achieve high yields and purity levels suitable for downstream applications.

From a computational chemistry perspective, molecular modeling studies have been instrumental in understanding the structural dynamics of tert-butyl 6-oxo-2,7-diazaspiro[4.5]decane-2-carboxylate. These studies have revealed insights into its binding interactions with biological targets, such as enzymes and receptors, which are critical for designing molecules with enhanced potency and selectivity. The integration of machine learning algorithms has further accelerated the process of virtual screening and lead optimization using this scaffold.

The pharmacological potential of tert-butyl 6-oxo-2,7-diazaspiro[4.5]decane-2-carboxylate has been explored in several preclinical studies. Researchers have investigated its effects on various biological pathways, including those implicated in inflammation, pain modulation, and neuroprotection. Preliminary findings suggest that derivatives of this compound may exhibit therapeutic benefits without significant side effects, making them attractive candidates for further development.

One notable area of research has been the application of tert-butyl 6-oxo-2,7-diazaspiro[4.5]decane-2-carboxylate in the development of kinase inhibitors.Spirocyclic compounds have shown promise in disrupting aberrant signaling pathways associated with cancer and inflammatory diseases.Specifically,the nitrogen-rich core of this molecule can interact with key residues in kinase domains,nucleating conformational changes that inhibit enzyme activity.Modelling studies indicate that subtle modifications to the spirocycle can enhance binding affinity without compromising selectivity.

Another emerging application lies in its use as a chiral building block for asymmetric synthesis.Chiral spirocycles are increasingly recognized for their role in producing enantiomerically pure drugs with improved efficacy and reduced toxicity.The tert-butyl group serves as an effective protecting group during synthetic manipulations while maintaining stereochemical integrity once installed on biologically relevant scaffolds.Recent reports highlight its utility in constructing complex heterocycles via transition-metal-catalyzed reactions.

The industrial production of tert-butyl 6-oxo-2,7-diazaspiro[4.5]decane-2-carboxylate has also seen advancements with continuous flow chemistry technologies.Flow reactors enable scalable synthesis while improving yield consistency and reducing solvent consumption compared to traditional batch processes.These innovations align with green chemistry principles by minimizing waste generation throughout manufacturing。

In conclusion,Tert-butyl 6-oxo-2,7-diazaspiro[4.5]decane-2-carboxylate (CAS No. 1228631-64-8) represents a structurally intriguing compound with broad applications across pharmaceutical research.Scientific investigations continue to uncover new possibilities for this scaffold through interdisciplinary approaches combining organic synthesis,molecular modelling,and preclinical assessment.As our understanding deepens,the full therapeutic potential of spirocyclic derivatives will likely expand further into uncharted therapeutic areas。

• 1194376-44-7(tert-Butyl 6-oxo-2,7-diazaspiro[4.4]nonane-2-carboxylate)
• 923009-50-1(tert-butyl 1-oxo-2,9-diazaspiro[4.5]decane-9-carboxylate)
• 1160246-71-8(tert-butyl 1-oxo-2,6-diazaspiro[3.5]nonane-6-carboxylate)
• 923009-54-5(tert-butyl 1-oxo-2,8-diazaspiro[5.5]undecane-8-carboxylate)
• 923009-51-2(Tert-butyl 2-ethyl-1-oxo-2,9-diazaspiro[4.5]decane-9-carboxylate)
• 923011-08-9(2,7-Diazaspiro[4.5]decane-7-carboxylic acid, 2-Methyl-1-oxo-, 1,1-diMethylethyl ester)
• 1061683-09-7(2,8-Diazaspiro[4.5]decane-8-carboxylic acid, 2-methyl-1-oxo-, 1,1-dimethylethyl ester)
• 937724-76-0(tert-Butyl 3-(piperidine-1-carbonyl)piperidine-1-carboxylate)
• 937724-78-2(tert-Butyl 3-(pyrrolidine-1-carbonyl)piperidine-1-carboxylate)
• 1160246-76-3(tert-butyl 1,3-dioxo-2,9-diazaspiro[4.5]decane-9-carboxylate)